Arena Pharmaceuticals Inc (ARNA)

63.27 -1.36  -2.10% NASDAQ Aug 7, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/06/2020 16:30 EST Misc Arena Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
11/06/2020 Earnings Arena Pharmaceuticals Inc Third Quarter Earnings for 2020 Release
08/05/2020 16:30 EDT Misc Arena Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Arena Pharmaceuticals Inc Second Quarter Earnings Result for 2020
06/12/2020 09:00 PDT Misc Arena Pharmaceuticals Inc Annual General Meeting for 2019
05/07/2020 16:30 EDT Misc Arena Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/07/2020 Earnings Arena Pharmaceuticals Inc First Quarter Earnings Result for 2020
02/27/2020 Misc Arena Pharmaceuticals Inc Annual Report for 2019
02/26/2020 16:30 EST Misc Arena Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/26/2020 Earnings Arena Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.arenapharm.com
  • Investor Relations URL: http://invest.arenapharm.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 06, 2020
  • Last Earnings Release: Aug. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Top Fund Holders

Symbol Name Weighting
YOLO AdvisorShares Pure Cannabis ETF 4.98%
MJ ETFMG Alternative Harvest ETF 3.60%
DLRHX Delaware Healthcare R 2.77%
SBIO ALPS Medical Breakthroughs ETF 2.55%
TOKE Cambria Cannabis ETF 2.15%
SZCTX DWS Small Cap Core T 1.65%
JSSOX JHancock New Opportunities R2 1.53%
NBMVX Neuberger Berman Small Cap Growth Adv 1.44%
IHSVX Hartford Small Company R6 1.19%
MISCX BNY Mellon Small Cap Multi-Strategy Inv 0.76%
IWN iShares Russell 2000 Value ETF 0.36%
VTWV Vanguard Russell 2000 Value ETF 0.31%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.